Exhaled nitric oxide and clinical phenotypes of childhood asthma

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  Mahut, Bruno ^a,b,c   Peyrard, Séverine ^b   Delclaux, Christophe ^b,c,d  

^a Cabinet La Berma   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Mosquito Respiratory Research Group   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EXHALED NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT;

ARTICLE; ASTHMA; BODY HEIGHT; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTAL SMOKING; SEX DIFFERENCE; TREATMENT RESPONSE; ADOLESCENT; BREATH ANALYSIS; CLUSTER ANALYSIS; DRUG EFFECT; EXHALATION; FRANCE; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; RESIDUAL VOLUME; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; STATISTICAL MODEL; TOTAL LUNG CAPACITY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CHILD; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; EXHALATION; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LUNG; MALE; NITRIC OXIDE; PARIS; PLETHYSMOGRAPHY; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; RESIDUAL VOLUME; RISK ASSESSMENT; RISK FACTORS; SPIROMETRY; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 79956212780     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-65     Document Type: Article

References (37)

1. Mahut B, Delclaux C, Tillie-Leblond I, Gosset P, Delacourt C, Zerah-Lancner F, Harf A, de Blic J: Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J Allergy Clin Immunol 2004,113(2):252-256.
2. Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C: The link between exhaled NO and bronchomotor tone depends on the dose of inhaled steroid in asthma. Respir Med 2010,104(7):945-50.
3. Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC: An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol 2010,45(2):174-181.
4. Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, Jala M, Bidaud-Chevalier B, Dinh-Xuan AT, Randrianarivelo O, et al.: Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity. Allergy 2010,65(5):636-644.
5. Mahut B, Delacourt C, Zerah-Lancner F, De Blic J, Harf A, Delclaux C: Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004,125(3):1012-1018.
6. Mahut B, Peiffer C, Thibaudon M, Chevalier-Bidaud B, Defrance-Hutinet MF, Trinquart L, Delclaux C: What does a single exhaled nitric oxide measurement tell us in asthmatic children? J Asthma 2009,46(8):810-814.
7. Laoudi Y, Nikasinovic L, Sahraoui F, Grimfeld A, Momas I, Just J: Passive smoking is a major determinant of exhaled nitric oxide levels in allergic asthmatic children. Allergy 2010,65(4):491-497.
8. Delclaux C, Mahut B, Zerah-Lancner F, Delacourt C, Laoud S, Cherqui D, Duvoux C, Mallat A, Harf A: Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002,165(3):332-337.
9. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M, et al.: Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010,181(10):1033-1041.
10. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, et al.: Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010,182(5):598-604.
11. The Global Initiative for Asthma (GINA) [ http://www.ginasthma.com ] 2007.
12. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al.: An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009,180(1):59-99.
13. Mahut B, Peiffer C, Bokov P, Delclaux C, Beydon N: Use of specific airway resistance to assess bronchodilator response in children. Respirology 2011,16(4):666-671.
14. Bush A, Saglani S: Management of severe asthma in children. Lancet 2010,376(9743):814-825.
15. Mahut B, Bokov P, Delclaux C: Abnormalities of plethysmographic lung volumes in asthmatic children. Respir Med 2010,104(7):966-971.
16. Mahut B, Peiffer C, Bokov P, Beydon N, Delclaux C: Gas trapping is associated with severe exacerbation in asthmatic children. Respir Med 2010,104(8):1230-1233.
17. Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C: Lung Function Impairment Evidenced by Sequential Specific Airway Resistance in Childhood Persistent Asthma: A Longitudinal Study. J Asthma 2010,47(6):655-9.
18. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 2005,171(8):912-930.
19. Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C: The link between exhaled NO and bronchomotor tone depends on the dose of inhaled steroid in asthma. Respir Med 2010,104(7):945-950.
20. Zapletal A, Samanek M: [Flow resistance of airways and pulmonary flow resistance in children and juveniles. Normal values and their significance for the evaluation of airway obstruction]. Cesk Pediatr 1977,32(9):513-522.
21. Quanjer PH, Borsboom GJ, Kivastik J, Merkus PJ, Hankinson JL, Houthuijs D, Brunekreef B, Ihorst G, Kuhr J: Cross-sectional and longitudinal spirometry in children and adolescents: interpretative strategies. Am J Respir Crit Care Med 2008,178(12):1262-1270.
22. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH: Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008,178(3):218-224.
23. Kaiser H: The varimax criterion for analytic rotation in factor analysis. Psychometrika 1958, 23:187-200.
24. Hartigan JA, Wong MA: Algorithm AS 136: a K-means clustering algorithm. Appl Stat 1978, 28:100-108.
25. Ding C, He X: K-means Clustering via Principal Component Analysis. Proc of Int'l Conf Machine Learning (ICML 2004): 2004 2004, 225-232.
26. de Blic J, Boucot I, Pribil C, Robert J, Huas D, Marguet C: Control of asthma in children: still unacceptable? A French cross-sectional study. Respir Med 2009,103(9):1383-1391.
27. Schleich FN, Seidel L, Sele J, Manise M, Quaedvlieg V, Michils A, Louis R: Exhaled nitric oxide thresholds associated with a sputum eosinophil count >= 3% in a cohort of unselected patients with asthma. Thorax 2010,65(12):1039-1044.
28. Merkus PJ, Borsboom GJ, Van Pelt W, Schrader PC, Van Houwelingen HC, Kerrebijn KF, Quanjer PH: Growth of airways and air spaces in teenagers is related to sex but not to symptoms. J Appl Physiol 1993,75(5):2045-2053.
29. Litonjua AA, Sparrow D, Weiss ST: The FEF25-75/FVC ratio is associated with methacholine airway responsiveness. The normative aging study. Am J Respir Crit Care Med 1999,159(5 Pt 1):1574-1579.
30. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST: Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008,122(5):921-928 e924.
31. Mahut B, Refabert L, Marchac V, Iniguez JL, Aubertin G, Tamalet A, Lebras MN, Troadec C, Chatellier G, Delclaux C: Influenza-like illness responsible for severe exacerbations in asthmatic children during H1N1 pandemic: a survey before vaccination. J Asthma 2011,48(3):224-227.
32. Mahut B, Trinquart L, Delclaux C: Influence of age on the risk of severe exacerbation and asthma control in childhood. J Asthma 2011,48(1):65-68.
33. Megas F, Benmedjahed K, Lefrancois G, Mueser M, Dusser D: [The "Compli'Asthme" therapeutic observation survey on good use of inhaled drugs for asthma: perception by general practitioners]. Rev Pneumol Clin 2004,60(3):158-165.
34. Tadie JM, Henno P, Leroy I, Danel C, Naline E, Faisy C, Riquet M, Levy M, Israel-Biet D, Delclaux C: Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008,294(3):489-497.
35. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB: Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009, (4):CD006340.
36. Mahut B, Delclaux C: Peripheral airway/alveolar nitric oxide concentration in asthma. Thorax 2010. E-pub Alert
37. Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC: Clinical patterns in asthma based on proximal and distal airway nitric oxide categories. Respir Res 2010, 11:47.